A 24-year-old man, a country dweller, woke up on the morning of 21 August 1977 with a red and painful right eye. The symptoms gradually worsened, with watering and blurring of vision. He consulted an eye surgeon on 26 August 1977. He was diagnosed as having a comeal ulcer of possibly bacterial origin and treated with atropine and framycetin eye drops 3 times a day. He also received a combination of 400 000 units of penicillin and 0 5 g streptomycin intramuscularly daily. As there was no improvement after 5 days of treatment the patient was referred to one of us (M. P. U.).
Examination on 2 September 1977 showed his vision was only of hand movements, the right upper lid was swollen with blepharospasm, and there was marked circumcorneal congestion. Slit-lamp examination of the cornea showed a dead white plaque of cheesy excrescent material (Fig. 1 The patient was treated with framycetin drops hourly during the day and 2-hourly by night, 2 tablets twice daily of Septrin (sulphamethoxazole, trimethoprim, and co-trimoxazole), and vitamin B-complex and vitamin C twice daily. Once bacterial cultures were reported negative, Septrin was stopped and framycetin reduced to 4 times a day. Fungal culture was reported as a rapidly growing fungus with following sensitivity: amphotericin- (Holt, 1975 (Jones, 1975; Upadhyay, in press ). Nystatin, because of its inability to penetrate the cornea and lack of absorption from the gut (Goodman and Gilman, 1970) is not of much value in ophthalmology except for the most superficial corneal infections. In countries in which clotrimazole is available this imidazole would appear to be the drug of first choice for aspergillus infections of the eye (Jones et al., 1974) . Similarly miconazole and econazole have a high level of activity and are effective against ocular aspergillus (Jones, 1975) .
However, we were keen to test a drug which is more freely available in many parts of the world and which is known to be non-irritant to the eye and to penetrate the ocular tissues well from topical administration.
Thiabendazole is a well-known broad spectrum anthelminthic and its in-vitro antimycotic activities were reported by Robinson et al. (1964) . In-vivo antifungal effects were reported by Fleischmajer et al (1965) . Thiabendazole has been shown to be an effective antifungal against both pathogenic and (Robinson et al., 1969) . Strains of Aspergillusfiavus, including those known to produce aflatoxins, are highly susceptible. Robinson and his associates reported on thiabendazole's ability to penetrate ocular tissues (Robinson et al., 1966) . It has been shown that, if applied locally to the rabbit eye in concentrations up to 4%, it is non-irritating (Robinson et al., 1965) . This was confirmed in our case both subjectively by patient inquiry and objectively by daily slit-lamp examination of the eye.
Wilson and his associates investigated the effect of a topical application of thiabendazole in a corneal infection due to Phialophora verrucosa. Although in vitro tests had shown the isolate to be sensitive to thiabendazole, this drug could not eradicate the corneal infection (Wilson et al., 1966) . Sensitivity of Fusarium species to thiabendazole was reported by Jones (1975) , but in this case, although infection was eliminated, the eye could not be saved, having to be removed due to advanced fungal malignant glaucoma. Ocular penetration from topical administration has been demonstrated (Robinson et al., 1966) . Thirty minutes to 1 hour after application of 20 mg of the 14C drug as 0 5 ml of a 4% suspension the cornea contained 42 to 52 .ug/g, the aqueous 18 to 28 ,ug/g, vitreous 0 5 to 1 ,ug/g, and the lens 2 to 3-4 t±g/g. 
